MAGCX
Price
$26.36
Change
-$0.75 (-2.77%)
Updated
Dec 18 closing price
RWIBX
Price
$62.66
Change
-$1.77 (-2.75%)
Updated
Dec 18 closing price
Ad is loading...

MAGCX vs RWIBX

Header iconMAGCX vs RWIBX Comparison
Open Charts MAGCX vs RWIBXBanner chart's image
BlackRock Advantage Global Institutional
Price$26.36
Change-$0.75 (-2.77%)
VolumeN/A
CapitalizationN/A
American Funds Capital World Gr&Inc R2
Price$62.66
Change-$1.77 (-2.75%)
VolumeN/A
CapitalizationN/A
MAGCX vs RWIBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MAGCX vs. RWIBX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MAGCX is a StrongBuy and RWIBX is a Buy.

FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 121B vs. MAGCX (384M). MAGCX pays higher dividends than RWIBX: MAGCX (1.32) vs RWIBX (1.05). MAGCX was incepted earlier than RWIBX: MAGCX (30 years) vs RWIBX (23 years). MAGCX is a more actively managed with annual turnover of: 102.00 vs. RWIBX (27.00). RWIBX has a lower initial minimum investment than MAGCX: RWIBX (250) vs MAGCX (2000000). RWIBX annual gain was more profitable for investors over the last year : 11.34 vs. MAGCX (10.38). RWIBX return over 5 years is better than : 29.64 vs. MAGCX (28.02).
MAGCXRWIBXMAGCX / RWIBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence30 years23 years-
Gain YTD8.8959.78191%
Front LoadN/AN/A-
Min. Initial Investment2000000250800,000%
Min. Initial Investment IRAN/AN/A-
Net Assets384M121B0%
Annual Yield % from dividends1.321.05126%
Returns for 1 year10.3811.3492%
Returns for 3 years13.638.41162%
Returns for 5 years28.0229.6495%
Returns for 10 years25.4244.2257%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LITM0.180.03
+17.46%
Snow Lake Resources Ltd
NUVB2.810.12
+4.46%
Nuvation Bio
ENTG109.362.65
+2.48%
Entegris
ARQ7.01-0.04
-0.57%
Arq
PTCT47.02-1.59
-3.27%
PTC Therapeutics